Nelarabine Injection
Product Images NDC 72205-154

This is a description of a pharmaceutical product, Nelarabine Injection, containing 250 mg of nelarabine per 50 mL at a concentration of 5 mg/mL. It is intended for intravenous infusion only, and any unused portion should be discarded. The product comes in 6 individual 50mL single-dose vials with the NDC code 7220515404 and is manufactured by SN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals in Piscataway, NJ. The packaging includes specific instructions on storage conditions and handling precautions. The text also mentions the presence of additional ingredients such as sodium chloride, water for injection, sodium hydroxide, and hydrochloric acid.*

This is a detailed description of Nelarabine Injection, a medication used for intravenous infusion. The medication comes in a 50mL single-dose vial containing 250mg of nelarabine. Each mL of the solution contains 5mg of nelarabine along with sodium chloride for tonicity adjustment and other additives. The vial stoppers are latex-free, and the solution should not be used if cloudy or contains precipitate. It is recommended to store the medication at room temperature between 15°C to 30°C. The medication is distributed by Novadoz Pharmaceuticals and manufactured by MSN Laboratories in India. The package insert should be consulted for usual doses.*

This is a description of Nelarabine Injection, a medication administered intravenously. Each mL contains 5 mg of nelarabine and the vial of 50 mL has a concentration of 250 mg. It is a single-dose vial with no preservatives and the stoppers are latex-free. The medication should not be diluted and should be stored at 25°C with excursions permitted between 15°C to 30°C. Usual doses can be found in the package insert. The drug is manufactured by MSN Laboratories in India and distributed by Novadoz Pharmaceuticals in the US. The lot number, expiration date, and variable data are coded on the packaging for tracking purposes.*